ROCSTAR: Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall Hernias
Study Details
Study Description
Brief Summary
In the treatment of ventral incisional hernias, a mesh repair in the retromuscular plane is considered as the gold standard. To allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias, component separation techniques are increasingly being used. When compared to anterior component separation, posterior component separation by transversus abdominis release (TAR) seems to decrease postoperative wound problems. While laparoscopic techniques pose significant difficulties to perform TAR minimally invasively (mainly due to ergonomic and technical reasons), these limitations seem to be overcome by robotic platforms. Initial retrospective patient series report on significantly shorter postoperative hospital stay and fewer complications after robotic transversus abdominis release (rTAR), when compared to open transversus abdominis release (oTAR). High-quality prospective evidence on rTAR is currently lacking.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Robotic-assisted repair of wide ventral incisional hernia Robotic |
Procedure: Component separation (transversus abdominis release)
Component separation by transversus abdominis release, to allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias.
|
Active Comparator: Open repair of wide ventral incisional hernia Open |
Procedure: Component separation (transversus abdominis release)
Component separation by transversus abdominis release, to allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias.
|
Outcome Measures
Primary Outcome Measures
- Length of postoperative hospital stay [From date of operation until the date of discharge, assessed up to 20 days]
Length of postoperative hospital stay
Secondary Outcome Measures
- Skin-to-skin operative time [Per-operative (minutes)]
Skin-to-skin operative time
- Conversion rate [Per-operative]
Conversion rate
- Postoperative complication rate [30 days]
Surgical site infection - surgical site occurrence - surgical site occurrence requiring procedural interventions
- Readmission and reoperation rate [30 Days]
Readmission and reoperation rate
- Post-anesthetic discharge scoring system [Immediately after the surgery]
Minimum score is 0, maximum score is 12. The higher the score, the better the outcome.
- Postoperative visual analogue scale pain score [Immediately after the surgery]
Minimum score is 0, maximum score is 10. The higher the score, the worse the outcome.
- Quality of Life Scoring [Preoperatively, 30 days, 3 months, 12 months, 24 months, 60 months]
Minimum score is 0, maximum score is 90. The higher the score, the worse the outcome.
- Body image score [Preoperatively, 30 days, 3 months, 12 months, 24 months, 60 months]
Minimum score is 0, maximum score is 10. A higher score means a higher level of body image disturbance (worse outcome).
- Hernia recurrence [3 Months, 12 months, 24 months, 60 months]
Hernia recurrence
- Reoperation for hernia recurrence or abdominal surgery not for hernia recurrence [3 Months, 12 months, 24 months, 60 months]
Reoperation for hernia recurrence or abdominal surgery not for hernia recurrence
Eligibility Criteria
Criteria
Inclusion Criteria:
- All patients with a ventral incisional hernia of more than 8 centimeters in width
Exclusion Criteria:
-
Emergency surgery
-
Pregnancy
-
Age<18
-
Incisional hernia repair after open abdomen or enterocutaneous fistula
-
Active wound infection
-
Previous anterior or posterior component separation
-
Absence of a signed informed consent
-
Patients unable to give informed consent or complete the quality-of-life assessment (due to language barriers or intellectual capacity)
-
Primary ventral hernias
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Algemeen Ziekenhuis Maria Middelares
Investigators
- Principal Investigator: Filip Muysoms, MD PhD, Clinical research center Maria Middelares
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ROCSTAR